Since p53-R175H has the highest occurrence (5.98%) in breast cancer and p53-R249S also has high-level of amyloid-like p53 aggregates, these two mutants were used to investigate the role of BAG2 in the formation of mutant p53 aggregates. This evidence concerns the gene BAG2 and breast cancer.